Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

Fish oil cut insulin resistance by 2.06 standard deviations in MASLD patients — a huge effect, but other metabolic measures like BMI and HDL didn't change.
- 2025-01-24
- Systematic Review
- n = 439
- Frontiers in nutrition
This meta-analysis provides early evidence that fish oil may powerfully improve a key marker of metabolic health in people with fatty liver disease, but the benefit appears limited to that clinical population and didn't extend to weight or cholesterol.
Big effectFish Oil for Reduced HOMA-IR
A meta-analysis of supplements for competitive swimmers found beta-alanine failed to improve performance — joining caffeine and sodium bicarbonate in the null column, with only creatine showing a statistically significant effect.
- 2025-04-09
- Meta-Analysis
- Journal of the International Society of Sports Nutrition
This is one of the first indexed meta-analyses on beta-alanine for swimming, so the null result challenges the popular belief that it helps — but the evidence base is still thin, so the picture is contested rather than settled.
Myth-busterBeta-Alanine for Improved Swimming Performance
Iron supplementation achieved the highest SUCRA ranking (56.54%) for lowering heart rate at altitude — but the benefit was not statistically significant in a systematic review of 329 people.
- 2025-11-04
- Systematic Review
- n = 329
- Frontiers in nutrition
This contradicts the common belief that iron reliably improves heart rate during high-altitude exercise, but because this is among the first systematic reviews on the specific pairing and the dose wasn't specified, the evidence is still too preliminary to change any recommendations.
Myth-busterIron for Reduced Heart Rate
Eczema incidence dropped from 67% to 26% in infants given a specific probiotic strain — but the result comes from a single Chinese trial that also saw fewer infections, leaving generalization uncertain.
- 2026-02-15
- RCT
- n = 180
- Clinical and experimental pediatrics
This is the first indexed study on Bifidobacterium animalis subsp. lactis BLa80 for eczema, so while the effect size is striking, it needs replication before we can confidently say the benefit extends beyond this population and these co-measured outcomes.
Big effectBifidobacterium bifidum Bb-02 for Reduced Eczema Incidence
A double-blind trial found that 600 mg of N-acetyl cysteine taken twice daily slashed the rate of a dangerous platelet-drop from 41.6% to 16.8% in critically ill patients on linezolid — though the results come from a single study in a very specific, sick population and need replication before they apply more broadly.
- 2026-03
- RCT
- Environmental toxicology and pharmacology
This is one of the first rigorous trials to show NAC can prevent a serious side effect of a common antibiotic, but the finding is so novel that it should be treated as promising preliminary evidence, not a settled benefit for everyone.
Big effectN-Acetyl Cysteine for Reduced Thrombocytopenia
A systematic review of 415 adults found vitamin D linked to autoimmune protection in some studies — but most trials showed no significant benefits.
- 2025-07-04
- Systematic Review
- n = 415
- BMC nutrition
This is among the first systematic reviews on vitamin D for autoimmune protection in healthy adults, so the positive finding is intriguing but far from settled — especially since most outcomes in the same review (like blood pressure and cholesterol) showed no effect.
New evidenceVitamin D for Reduced Autoimmune Reaction
Swapping half your daily staple for quinoa boosted blood-sugar time-in-range over a year — but the study was open-label, so expectations should be tempered.
- 2025
- RCT
- n = 207
- Food & function
This is one of the first long-term trials to pit quinoa directly against other whole grains, and the results are promising for people with impaired glucose tolerance — but because neither participants nor researchers knew which group they were in, the real-world advantage may be smaller than reported.
Surprisingquinoa for Increased Time in Range
Calcium tied to a 7% lower colorectal cancer risk in Asian meta-analysis — but the confidence interval crossed 1.0, meaning no statistical significance
- 2025-08-27
- Meta-Analysis
- Cancer causes & control : CCC
This is one of the first meta-analyses on calcium and colorectal cancer in Asian populations, and the borderline result means the protective effect is far from settled — treat the finding as hypothesis-generating, not conclusive.
Myth-busterCalcium for Reduced Risk of Colorectal Cancer
A meta-analysis of genetic studies found coffee consumption had no statistically significant link to liver cancer risk (OR 0.92, 95% CI 0.58–1.47) — challenging earlier observational reports that suggested a protective effect.
- 2025-08-25
- Meta-Analysis
- Gut and liver
This is among the first indexed studies using genetic data to test the coffee–liver cancer link, so the null result casts doubt on the previously believed benefit but doesn't settle the debate — more research is needed before changing any habits.
Myth-busterCoffee for Reduced Hepatocellular Carcinoma Risk
Kefir slashed HOMA-IR by 1.71 points in a meta-analysis — but the same review found no effect on weight, waist size, cholesterol, or inflammation.
- 2026-05
- Meta-Analysis
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is a large, statistically significant drop in a key marker of insulin resistance, but it comes from only three studies, and the fact that kefir didn't budge any other metabolic or inflammatory measure means the benefit appears narrow — and may not translate into the broader health improvements you'd expect.
Big effectKefir for Reduced HOMA-IR
Probiotic Bacillus coagulans increased bowel movements and improved stool consistency in a 111-person trial — but it’s one of the first solid studies on this specific pairing.
- 2025-07-22
- RCT
- n = 111
- Beneficial microbes
This is an early, well-designed trial suggesting the probiotic helps with constipation and bowel regularity, but a single study — even a rigorous one — isn’t enough to call the effect established.
New evidenceBacillus coagulans GBI-30, 6086 for Improved Gastrointestinal Function
Extremely preterm infants given L. reuteri scored 7 points higher on language at age 2 — but cognition, motor skills, and growth remained unchanged.
- 2025-02-13
- RCT
- n = 134
- Acta paediatrica (Oslo, Norway : 1992)
This early finding suggests a possible selective benefit for language, but it comes from a single trial in a fragile, clinical population — far from a general recommendation.
SurprisingLactobacillus reuteri DSM 17938 for Improved Language Score
In a 24-week trial, vitamin E failed to budge the NAFLD fibrosis score in non-diabetic MASLD patients — a -0.12 point change that didn't reach statistical significance.
- 2026-05-16
- RCT
- n = 136
- The Indian journal of medical research
This open-label trial contradicts the common notion that vitamin E helps liver scarring in fatty liver disease, but because the study was small (136 people), unblinded, and short-term, the debate is far from settled.
Myth-busterVitamin E for Reduced NAFLD Fibrosis Score
1 g/day fish oil reduced a key inflammation marker by 24% in older adults — but 2 g and 4 g doses got no extra benefit.
- 2026
- RCT
- n = 240
- Food & function
This is one of the first rigorous human trials to test low-dose fish oil on vessel-wall inflammation, but a single study in elders — even a good one — can't yet settle the dose question or prove clinical impact.
New evidenceFish Oil for Reduced ICAM-1 Level
Probiotics failed to shift Shannon diversity, species richness, or other key gut bacteria metrics in a meta-analysis of healthy adults — a null result that runs counter to popular claims.
- 2026-01-07
- Meta-Analysis
- BMC medicine
This meta-analysis pools multiple randomized trials, making it a stronger test than any single study, but because it looked at probiotics broadly, it doesn't rule out that specific strains like Pediococcus acidilactici R1001 might work in certain people or conditions — and the body of evidence for this exact pairing is still thin.
Myth-busterPediococcus acidilactici R1001 for Maintained Gut Microbiota Diversity
Probiotics halved the risk of chemotherapy-induced diarrhea in colorectal cancer patients — but the benefit didn't extend to inflammatory biomarkers.
- 2025-07-04
- Meta-Analysis
- n = 1,526
- Medicine
This is the strongest evidence yet for this specific probiotic strain in a clinical setting, but because it's among the first meta-analyses on the pairing, the results need replication before they can be generalized to all cancer patients or other probiotic formulations.
Big effectBifidobacterium infantis HA-116 for Reduced Chemotherapy-Induced Diarrhea
A meta-analysis of 16 trials linked a probiotic to a large reduction in eczema severity (SMD –4.24) — but the effect was strain-specific and the dose wasn't reported.
- 2025-06-03
- Systematic Review
- n = 502
- Frontiers in nutrition
This is a strong signal for Lactobacillus GG in children with food allergies, but the analysis relied on indirect comparisons and the results may not generalize to adults or to other strains like Bifidobacterium bifidum BB-06, which was included but not highlighted as the top performer.
Big effectBifidobacterium bifidum BB-06 for Improved Allergic Symptoms
A systematic review found synbiotic treatments linked to reduced painkiller use in migraine — alongside cuts in frequency, severity, and duration — though the evidence comes from only six, mostly small trials.
- 2025-05-21
- Systematic Review
- The journal of headache and pain
This is early but promising evidence that targeting the gut microbiome with pre- and probiotics might help manage migraine, but with few studies and no specified dose or long-term data, it's far from a settled recommendation.
New evidenceStreptococcus thermophilus PXN 66 for Reduced Painkiller Consumption
Vitamin E plus levocarnitine slashed cardiac event odds by 73% in chemo patients — but the combo was tested in only one small trial among 28 studies.
- 2025-09-03
- Systematic Review
- n = 858
- Frontiers in cardiovascular medicine
This is the first systematic review to flag this supplement pairing as potentially protective during anthracycline chemotherapy, but with just 858 patients across all trials and no specified dose, it’s a promising lead — not a recommendation.
New evidenceL-Carnitine for Reduced Cardiac Event
In an open-label trial of 874 pregnant women, 200 mg/day lactoferrin was linked to 75% fewer asymptomatic bacteriuria episodes — but the lack of blinding and narrow population demand caution.
- 2025-04-23
- RCT
- n = 874
- BMC urology
This is the first solid randomized trial on lactoferrin for urinary tract infections, but it was open-label (no placebo) and tested only in pregnant Egyptian women with recurrent UTIs, so the results may not apply to other groups and need replication.
New evidenceLactoferrin for Reduced Asymptomatic Bacteriuria Episode
A meta-analysis found garlic lowered systolic blood pressure by 4.21 mmHg on average — but the effect was clearest in people already obese or aged 50–60, and came with a side of bad breath and GI discomfort.
- 2025-11-28
- Systematic Review
- Frontiers in nutrition
This is one of the first systematic reviews to pool data on long-term garlic for hypertension, so the picture is still emerging — the modest drop in blood pressure is real but not a standalone fix, and it matters most for specific subgroups, not everyone.
Myth-busterGarlic for Reduced Systolic Blood Pressure
Adding a probiotic cut diarrhea risk by 55% in a meta-analysis of 2,054 people on H. pylori treatment — but the evidence can't say which specific strain was responsible.
- 2025-12
- Meta-Analysis
- n = 2,054
- MicrobiologyOpen
This is one of the first meta-analyses to show a large, statistically robust reduction in a common antibiotic side effect, but because the analysis lumped together many different probiotic strains without isolating Bifidobacterium breve Bb-18's unique contribution, the finding is a promising signal rather than a prescription.
Big effectBifidobacterium breve Bb-18 for Reduced Diarrhea
Silymarin from milk thistle beat resveratrol on HbA1c in a meta-analysis of 337 patients — but this is the first systematic look at the pairing, so the finding is still provisional.
- 2025-05-29
- Systematic Review
- n = 337
- Phytotherapy research : PTR
This is early evidence that silymarin might lower long-term blood sugar more than other popular herbal supplements, but with only 337 patients across the included studies and no specified dose, the result needs replication before you should act on it.
New evidenceThistle for Reduced Hemoglobin A1c
A meta-analysis of 824 patients found vitamin E as an add-on therapy nearly doubled the chance of a >75% reduction in seizure frequency — but the effect comes from a small, early body of evidence and the dose used wasn't specified.
- 2025-07-11
- Systematic Review
- n = 824
- Frontiers in neurology
This is an unusually large effect for a supplement in epilepsy, but the finding is preliminary: it's among the first systematic reviews on this pairing, the studies were unblinded, and the benefit was clearest in children, so it may not apply broadly to adults or those on different drug regimens.
Big effectVitamin E for Reduced Seizure Frequency
A 12-week vegan diet plus soy dropped body weight by 3.4 kg more than controls – but the study's main target (severe hot flashes) didn't budge, making the weight loss an unexpected side finding.
- 2025-07-05
- RCT
- n = 84
- Maturitas
This is one of the first trials to link isoflavone intake — particularly daidzein — to weight loss in postmenopausal women, but the effect comes from a secondary analysis of a study designed to test hot flash relief (which failed), so treat the weight result as hypothesis-generating, not proof.
SurprisingPueraria for Reduced Body Weight
Curcumin matched NSAIDs for pain relief in an umbrella review — but the studies were too varied to crown a winner.
- 2026-05-21
- Systematic Review
- Frontiers in medicine
This is the strongest signal yet that curcumin can meaningfully reduce osteoarthritis pain, backed by 11 studies with a moderate effect size and no harmful results — but the high variability across trials means the exact benefit for any given person remains uncertain.
Big effectTurmeric for Reduced Pain
Vitamin E intake linked to 40% lower odds of developing COPD in early meta-analysis — but no effect on survival from the disease
- 2025
- Meta-Analysis
- n = 425
- Food & function
This is among the first meta-analyses to suggest vitamin E may help prevent COPD onset, but the same analysis found no benefit for preventing death from COPD, and the evidence base is still thin — treat it as promising but preliminary.
New evidenceVitamin E for Reduced Chronic Obstructive Pulmonary Disease Onset Risk
A meta-analysis of small vitamin D trials found a 0.88 odds ratio for ICU admission — but a subtle statistical signal shows those results may be a mirage, while larger trials found no benefit.
- 2025-01-14
- Meta-Analysis
- n = 548
- PloS one
This analysis suggests that the belief vitamin D prevents severe COVID-19 is likely built on small, flattering studies that got published because they were positive — the bigger, more reliable trials saw nothing.
Myth-busterVitamin D for Reduced Intensive Care Unit Admission
A meta-analysis of 355 patients found aloe vera cut the odds of severe oral mucositis by 78% during cancer therapy — but only against placebo, not against standard mouthwashes.
- 2025-07
- Meta-Analysis
- n = 355
- International journal of oral and maxillofacial surgery
This is the first pooled analysis of its kind, but the apparent benefit is contested because aloe vera failed to outperform sodium bicarbonate or benzydamine, meaning it may not be a clear upgrade over existing options.
Myth-busterAloe Vera for Reduced Severe Oral Mucositis
A randomized trial found L-arginine cleared lower ureter stones in 94% of people — but zeroed in on a narrow clinical population, and two other outcomes it measured showed no benefit.
- 2025-06-11
- RCT
- n = 162
- Urolithiasis
This single study suggests L-arginine may be unexpectedly effective at helping small kidney stones pass, but it tested only 162 hospitalized patients, and its failure to reduce pain or analgesic use means the real-world advantage might be narrower than the headline rate suggests.
SurprisingL-Arginine for Increased Spontaneous Stone Expulsion Rate